Applicability of the modified CHA(2)DS(2)-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients
Por:
García-Fernández A, Roldán V, Rivera-Caravaca JM, Lip GY and Marín F
Publicada:
1 mar 2017
Ahead of Print:
15 nov 2016
Categoría:
Internal medicine
Resumen:
Atrial fibrillation Stroke Risk prediction
Filiaciones:
:
Cardiology Service, Alicante University General Hospital, ISABIAL - FISABIO Foundation, Alicante, Spain.
Roldán V:
Department of Hematology and Clinical Oncology, Morales Meseguer University Hospital, University of Murcia, IMIB-Arrixaca, Murcia, Spain
Rivera-Caravaca JM:
Department of Cardiology, Virgen de la Arrixaca University Hospital, University of Murcia, IMIB-Arrixaca, Murcia, Spain
Lip GY:
University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, University of Birmingham, Birmingham, United Kingdom
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Marín F:
Department of Cardiology, Virgen de la Arrixaca University Hospital, University of Murcia, IMIB-Arrixaca, Murcia, Spain
|